Prostate Cancer - Results from #80

Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer. August 28, 2019

Imaging of prostate cancer with positron emission tomography. August 28, 2019

"Real-world" evaluation of 18F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy. August 28, 2019

An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer. August 28, 2019

Metastatic-directed therapy using PSMA-PET/CT at PSA relapse. August 28, 2019

Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy. August 28, 2019

Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells. August 28, 2019

Overexpression levels of cripto-1 predict poor prognosis in patients with prostate cancer following radical prostatectomy. August 28, 2019

Active surveillance for intermediate-risk prostate cancer: yes, but for whom? August 27, 2019

PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer. August 27, 2019

Serum Lipids Prior to Starting Androgen Deprivation Therapy and Risk of Castration-Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database. August 27, 2019

Exercise for advanced prostate cancer: a multicomponent, feasibility, trial protocol for men with metastatic castrate-resistant prostate cancer (EXACT). August 27, 2019

Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer. August 27, 2019

Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng/ml. August 26, 2019

Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancer. August 26, 2019

Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients. August 26, 2019

A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk. August 26, 2019

Long-term Outcomes for Men in a Prostate Screening Trial with an Initial Benign Prostate Biopsy: A Population-based Cohort. August 26, 2019

A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer. August 23, 2019

Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort. August 23, 2019

Page 5 of 1003

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.